POWERbreathe - Asthma
The role of inspiratory muscle training (IMT) in the management of asthma has been less widely studied than in COPD, but the data that exists from five randomised controlled trials are unanimously supportive.1,2,3,4,5
Patients experience a reduction in dyspnoea after as little as 3 weeks’ POWERbreathe training, as well as improvements in quality of life. Most striking are the observations that longer-term IMT reduces absence from school/work (by ~95%), use of healthcare resources (by ~75%), and the consumption of medication (by ~79%).
Patients experience a reduction in dyspnoea after as little as 3 weeks’ POWERbreathe training, as well as improvements in quality of life. Most striking are the observations that longer-term IMT reduces absence from school/work (by ~95%), use of healthcare resources (by ~75%), and the consumption of medication (by ~79%).
- Laboratory studies found asthma symptoms improved with IMT by up to 75% in 3 weeks
- Patients with asthma experienced improvement of symptoms, quality of life and a reduction in the consumption of medication of up to 79%
